Loading...
HomeMy WebLinkAboutMINUTES - 11032015 - C.77RECOMMENDATION(S): Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute a purchase order with Biomerieux, Inc. for $122,559 to purchase the upgrade of the Vitek 2XL, Vitek 2XL cart and Observa Ultra Lite for Vitek 2 for the Contra Costa Regional Medical Center (CCRMC) and the Contra Costa Health Centers. FISCAL IMPACT: 100% budgeted in the Hospital Enterprise Fund I. BACKGROUND: The Vitek 2XL is an automated microbiology instrument providing bacterial identification and susceptibility testing for the clinical laboratory at CCRMC. The Identification (ID) is used for naming the organism in a patient’s sample and the Antibiotic Susceptibility Testing (AST) helps determine which antibiotics to use to treat patients. This enables the testing to go significantly faster, which allows for rapid same day reporting. CONSEQUENCE OF NEGATIVE ACTION: The CCRMC Clinical Laboratory will not be able to perform patient testing in a timely manner and the current equipment won’t be able to keep up with the demand. CHILDREN'S IMPACT STATEMENT: Not applicable. APPROVE OTHER RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE Action of Board On: 11/03/2015 APPROVED AS RECOMMENDED OTHER Clerks Notes: VOTE OF SUPERVISORS AYE:John Gioia, District I Supervisor Candace Andersen, District II Supervisor Mary N. Piepho, District III Supervisor Karen Mitchoff, District IV Supervisor Federal D. Glover, District V Supervisor Contact: Anna Roth, (925) 370-5101 I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown. ATTESTED: November 3, 2015 David Twa, County Administrator and Clerk of the Board of Supervisors By: June McHuen, Deputy cc: T Scott, N Rios, Crystal Grayson C. 77 To:Board of Supervisors From:William Walker, M.D., Health Services Director Date:November 3, 2015 Contra Costa County Subject:Blanket Purchase Order with Biomerieux, Inc.